SCHEMBL21032256

SCHEMBL21032256

Cc1ccc(OC(F)F)c(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.53
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
MAPT P10636 4/20 0.44
LMNA P02545 4/20 0.44
HTT P42858 1/20 0.44
ATM Q13315 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPK1 P28482 1/20 0.38
POLB P06746 1/20 0.38
AR P10275 4/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
ACHE P22303 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
TRPA1 O75762 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12002404 0.85 RXRA (0.50) SYKSMN1; SMN2ARRXRARXRB
SCHEMBL12879059 0.85 ALDH1A1 (0.45) SYKALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL13499939 0.82 SYK (0.50) SYKSMN1; SMN2ARRXRARXRB
SCHEMBL10001984 0.80 SYK (0.54) SYKALDH1A1SMN1; SMN2ARACHE
SCHEMBL12180332 0.80 SYK (0.44) SYKSMN1; SMN2POLBARRXRA
SCHEMBL16174389 0.80 SYK (0.44) SYKSMN1; SMN2POLBARRXRA
SCHEMBL16342278 0.80 SYK (0.44) SYKALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL21030751 0.79 RXRA (0.39) SYKRXRARXRBRXRGSLC22A12
SCHEMBL13523552 0.79 SYK (0.53) SYKALDH1A1SMN1; SMN2ARACHE
SCHEMBL764998 0.79 ACHE (0.56) SYKALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO SYK 50/4885ALDH1A1 1217/4885MEN1 478/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO SYK 50/4885ALDH1A1 1217/4885MEN1 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.